Antitumor efficacy of cobalt–zinc ferrite nanoparticles on MCF-7 cell line and Ehrlich ascites carcinoma bearing mice
Mona M. Elwan, Eman E. El-Nahass, Sabry A. El-Naggar, B. I. Salem · 2026
Read Antitumor efficacy of cobalt–zinc ferrite nanoparticles on MCF-7 cell line and Ehrlich ascites carcinoma bearing mice by Mona M. Elwan, Eman E. El-Nahass, Sabry A. El-Naggar, B. I. Salem (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219608.txt.
Description
Mona M. Elwan and co-authors test cobalt-zinc ferrite nanoparticles against breast cancer in a 2026 study. Nanoparticles are explored as cancer treatments that might add firepower with fewer effects than chemotherapy. The particles were made by a flash-combustion method and checked with infrared spectroscopy and microscopy before cells were exposed.
Against MCF-7 breast cancer cells, the plain cobalt ferrite particles killed half the cells at a concentration of 144 micrograms per milliliter. Even a tenth of that dose pushed cells into programmed death and froze the cell cycle at two checkpoints. In mice carrying Ehrlich ascites tumors, treatment cut tumor volume by forty-four percent and reduced tumor cells, while blood counts and liver and kidney function improved and tissue looked healthier. The drug cisplatin was more potent per microgram in the dish, a gap the authors acknowledge while presenting the particles as an adjunct for nanotherapy.
Catalog record
| CREATOR | Mona M. Elwan, Eman E. El-Nahass, Sabry A. El-Naggar, B. I. Salem |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |